Quantitative Structure-Activity Relationship Machine Learning Models and their Applications for Identifying Viral 3CLpro- and RdRp-Targeting Compounds as Potential Therapeutics for COVID-19 and Related Viral Infections.


Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
27 Oct 2020
Historique:
received: 31 07 2020
accepted: 29 09 2020
entrez: 2 11 2020
pubmed: 3 11 2020
medline: 3 11 2020
Statut: epublish

Résumé

In response to the ongoing COVID-19 pandemic, there is a worldwide effort being made to identify potential anti-SARS-CoV-2 therapeutics. Here, we contribute to these efforts by building machine-learning predictive models to identify novel drug candidates for the viral targets 3 chymotrypsin-like protease (3CLpro) and RNA-dependent RNA polymerase (RdRp). Chemist-curated training sets of substances were assembled from CAS data collections and integrated with curated bioassay data. The best-performing classification models were applied to screen a set of FDA-approved drugs and CAS REGISTRY substances that are similar to, or associated with, antiviral agents. Numerous substances with potential activity against 3CLpro or RdRp were found, and some were validated by published bioassay studies and/or by their inclusion in upcoming or ongoing COVID-19 clinical trials. This study further supports that machine learning-based predictive models may be used to assist the drug discovery process for COVID-19 and other diseases.

Identifiants

pubmed: 33134697
doi: 10.1021/acsomega.0c03682
pmc: PMC7571315
doi:

Types de publication

Journal Article

Langues

eng

Pagination

27344-27358

Informations de copyright

© 2020 American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

Immunotherapy. 2010 Sep;2(5):637-50
pubmed: 20874647
Biochemistry. 2005 Aug 23;44(33):11241-53
pubmed: 16101308
J Am Chem Soc. 1988 Aug 1;110(18):5959-67
pubmed: 22148765
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3373-3378
pubmed: 30808733
Front Pharmacol. 2017 Aug 25;8:539
pubmed: 28890698
Science. 2020 May 15;368(6492):779-782
pubmed: 32277040
J Chem Inf Model. 2009 Aug;49(8):1857-65
pubmed: 19807194
J Hepatol. 2018 Apr;68(4):672-681
pubmed: 29756595
J Org Chem. 2008 Jun 20;73(12):4443-51
pubmed: 18505297
J Biomol Struct Dyn. 2020 Jul 21;:1-11
pubmed: 32692306
Ther Drug Monit. 2012 Dec;34(6):729-35
pubmed: 23128911
Science. 2020 Jun 19;368(6497):1331-1335
pubmed: 32321856
Chem Biol Drug Des. 2018 Oct;92(4):1750-1762
pubmed: 29877617
Antiviral Res. 2017 May;141:101-106
pubmed: 28216367
Am J Hematol. 2019 Dec;94(12):1325-1334
pubmed: 31490009
Cochrane Database Syst Rev. 2018 Mar 06;3:CD012282
pubmed: 29508377
Drug Dev Res. 2020 May 1;:
pubmed: 32356926
Nat Rev Drug Discov. 2019 Jun;18(6):463-477
pubmed: 30976107
J Biomol Struct Dyn. 2020 May 12;:1-12
pubmed: 32340562
J Biomol Struct Dyn. 2020 Jun 22;:1-10
pubmed: 32568618
Fundam Clin Pharmacol. 1999;13(2):145-53
pubmed: 10226758
ChemMedChem. 2009 Nov;4(11):1803-5
pubmed: 19774591
N Engl J Med. 2017 Jun 1;376(22):2134-2146
pubmed: 28564569
J Chem Inf Comput Sci. 2003 Mar-Apr;43(2):429-34
pubmed: 12653505
SAR QSAR Environ Res. 2020 Jul;31(7):511-526
pubmed: 32543892
Oncogene. 2006 Oct 30;25(51):6887-99
pubmed: 17072334
Cell Discov. 2020 Mar 16;6:14
pubmed: 32194980
Drugs. 2003;63(8):769-802
pubmed: 12662125
Science. 2003 Jun 13;300(5626):1763-7
pubmed: 12746549
Cell Mol Life Sci. 2014 Nov;71(22):4403-20
pubmed: 25080879
J Pharm Anal. 2020 Aug;10(4):313-319
pubmed: 32296570
J Mol Struct. 2021 Jan 15;1224:129026
pubmed: 32834115
J Hematol Oncol. 2016 Mar 09;9:21
pubmed: 26957112
Hypertension. 2004 May;43(5):993-1002
pubmed: 15007034
Life Sci. 2020 Jul 15;253:117592
pubmed: 32222463
N Engl J Med. 2014 May 22;370(21):1983-92
pubmed: 24795200
Molecules. 2016 Jul 28;21(8):
pubmed: 27483216
J Chem Inf Model. 2010 May 24;50(5):742-54
pubmed: 20426451
Bioorg Med Chem Lett. 2016 Jul 15;26(14):3346-3350
pubmed: 27234148
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
J Biol Chem. 2020 May 15;295(20):6785-6797
pubmed: 32284326
Arzneimittelforschung. 1986 Feb;36(2):176-83
pubmed: 3754450
J Med Chem. 1991 Feb;34(2):786-97
pubmed: 1995902
Sci Rep. 2019 Aug 21;9(1):12220
pubmed: 31434908

Auteurs

Julian Ivanov (J)

CAS, A Division of the American Chemical Society, Columbus, Ohio 43210-3012, United States.

Dmitrii Polshakov (D)

CAS, A Division of the American Chemical Society, Columbus, Ohio 43210-3012, United States.

Junko Kato-Weinstein (J)

CAS, A Division of the American Chemical Society, Columbus, Ohio 43210-3012, United States.

Qiongqiong Zhou (Q)

CAS, A Division of the American Chemical Society, Columbus, Ohio 43210-3012, United States.

Yingzhu Li (Y)

CAS, A Division of the American Chemical Society, Columbus, Ohio 43210-3012, United States.

Roger Granet (R)

CAS, A Division of the American Chemical Society, Columbus, Ohio 43210-3012, United States.

Linda Garner (L)

CAS, A Division of the American Chemical Society, Columbus, Ohio 43210-3012, United States.

Yi Deng (Y)

CAS, A Division of the American Chemical Society, Columbus, Ohio 43210-3012, United States.

Cynthia Liu (C)

CAS, A Division of the American Chemical Society, Columbus, Ohio 43210-3012, United States.

Dana Albaiu (D)

CAS, A Division of the American Chemical Society, Columbus, Ohio 43210-3012, United States.

Jeffrey Wilson (J)

CAS, A Division of the American Chemical Society, Columbus, Ohio 43210-3012, United States.

Christopher Aultman (C)

CAS, A Division of the American Chemical Society, Columbus, Ohio 43210-3012, United States.

Classifications MeSH